.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,846,961

« Back to Dashboard
Patent 7,846,961 protects PRESTALIA and is included in one NDA.

This patent has twenty-two patent family members in twenty-one countries.

Summary for Patent: 7,846,961

Title:.alpha. crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
Abstract: .alpha.-crystalline form of the compound of formula (I): ##STR00001## characterized by its powder X-ray diffraction diagram. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme.
Inventor(s): Coquerel; Gerard (Boos, FR), Lefebvre; Loic (Mont Saint Aignan, FR), Souvie; Jean-Claude (Pau, FR), Authouart; Pascale (Les Trois Pierres, FR)
Assignee: Les Laboratoires Servier (Suresnes Cedex, FR)
Application Number:12/224,369
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 6th percentile
Forward Citations: 2nd percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Symplmed Pharms Llc
PRESTALIA
amlodipine besylate; perindopril arginine
TABLET;ORAL205003-001Jan 21, 2015RXNo7,846,961► subscribeYY TREATMENT OF HYPERTENSION
Symplmed Pharms Llc
PRESTALIA
amlodipine besylate; perindopril arginine
TABLET;ORAL205003-002Jan 21, 2015RXNo7,846,961► subscribeYY TREATMENT OF HYPERTENSION
Symplmed Pharms Llc
PRESTALIA
amlodipine besylate; perindopril arginine
TABLET;ORAL205003-003Jan 21, 2015RXYes7,846,961► subscribeYY TREATMENT OF HYPERTENSION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,846,961

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France06 01748Feb 28, 2006
PCT Information
PCT FiledFebruary 26, 2007PCT Application Number:PCT/FR2007/000335
PCT Publication Date:September 07, 2007PCT Publication Number: WO2007/099217

International Patent Family for Patent: 7,846,961

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
South Korea20120001818► subscribe
South Korea20080106948► subscribe
Japan5255454► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc